Prospective Asian Multicenter Prostate Cancer Focal Therapy Study (ProAMFocal)
Recruiting · NCT06491056 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Focal Therapy for Prostate Cancer
What this trial is about
This is a multicenter observational study of patients undergoing focal therapy for prostate cancer in Asia
Who can take part
Age range
40 Years to 85 Years
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Prostate Adenocarcinoma
- Maximum Gleason score 4+4
- Maximum cancer volume 1.5 ml (up to 2 lesions) or 3 ml (single lesion)
- Maximum Prostate Specific Antigen (PSA) level 15 ng/dl
- Maximum clinical stage T2c
- American Society of Anesthesiologist Criteria 2 or less
Exclusion criteria
- Extra-prostatic Extension on multi parametric magnetic resonance imaging (mpMRI); capsular contact is permitted
Where it is running
1 location listed.
- Singapore General Hospital - Singapore, Singapore